User profiles for Robert Hüneburg

Robert Hüneburg

Department of Internal Medicine I, National Center for Hereditary Tumor Syndromes
Verified email at ukbonn.de
Cited by 2328

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

…, M Morak, S Holzapfel, R Hüneburg… - Genetics in …, 2020 - nature.com
Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome
and result in different but imprecisely known cancer risks. This study aimed to provide …

[PDF][PDF] Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype

…, ME Vink-Börger, I Popp, A Lang, I Spier, R Hüneburg… - Cancer cell, 2019 - cell.com
Biallelic germline mutations affecting NTHL1 predispose carriers to adenomatous polyposis
and colorectal cancer, but the complete phenotype is unknown. We describe 29 individuals …

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

…, N Hoogerbrugge, R Hüneburg… - The Lancet …, 2021 - thelancet.com
Background Existing clinical practice guidelines for carriers of pathogenic variants of DNA
mismatch repair genes (Lynch syndrome) are based on the mean age-specific cumulative risk …

No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies

…, R Büttner, E Holinski-Feder, S Holzapfel, R Hüneburg… - Gastroenterology, 2018 - Elsevier
Background & Aims Patients with Lynch syndrome are at high risk for developing colorectal
cancer (CRC). Regular colonoscopic surveillance is recommended, but there is no …

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

…, V Branchi, S Manekeller, R Hüneburg… - PLoS …, 2017 - journals.plos.org
Innate lymphocyte cells (ILCs), a novel family of innate immune cells are considered to
function as key orchestrators of immune defences at mucosal surfaces and to be crucial for …

Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C

…, A Hausen, L Dold, P van Heteren, R Hüneburg… - Journal of …, 2017 - Elsevier
Robert Hüneburg: aquisition of patients and clinical data; critical revision of the manuscript
for important intellectual content. Jacob Nattermann: critical revision of the manuscript for …

The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance

…, F Macrae, R Scott, R Hüneburg… - … journal of cancer, 2021 - Wiley Online Library
Individuals with Lynch syndrome (LS), one of the most common inherited cancer syndromes,
are at increased risk of developing malignancies, in particular colorectal cancer (CRC). …

[HTML][HTML] Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221 European patients and comparison with a literature-derived …

…, DG Evans, M Genuardi, FJ Hes, R Hüneburg… - Genetics in …, 2020 - Elsevier
Purpose Juvenile polyposis syndrome (JPS) is a rare, autosomal-dominantly inherited cancer
predisposition caused in approximately 50% of cases by pathogenic germline variants in …

The different immune profiles of normal colonic mucosa in cancer-free Lynch syndrome carriers and Lynch syndrome colorectal cancer patients

L Bohaumilitzky, K Kluck, R Hüneburg, R Gallon… - Gastroenterology, 2022 - Elsevier
Background & Aims Owing to the high load of immunogenic frameshift neoantigens, tumors
arising in individuals with Lynch syndrome (LS), the most common inherited colorectal …

Associations of pathogenic variants in MLH1, MSH2, and MSH6 with risk of colorectal adenomas and tumors and with somatic mutations in patients with Lynch …

…, V Endris, E Holinski-Feder, S Holzapfel, R Hüneburg… - Gastroenterology, 2020 - Elsevier
Background & Aims Lynch syndrome is caused by variants in DNA mismatch repair (MMR)
genes and associated with an increased risk of colorectal cancer (CRC). In patients with …